← Back to Clinical Trials
Recruiting NCT06105970

NCT06105970 Chinese Community Sample of Hierarchical Model of Psychopathology

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06105970
Status Recruiting
Phase
Sponsor Shanghai Mental Health Center
Condition Mental Health Issue
Study Type OBSERVATIONAL
Enrollment 4,000 participants
Start Date 2023-09-26
Primary Completion 2024-11-01

Trial Parameters

Condition Mental Health Issue
Sponsor Shanghai Mental Health Center
Study Type OBSERVATIONAL
Phase N/A
Enrollment 4,000
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2023-09-26
Completion 2024-11-01
Interventions
No intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

By validating Hierarchy Model of psychopathology(HiTOP) in Chinese community samples, this study aims for illumating the problem of diagnostic heterogeneity and high comorbidity within existing psychiatric classification systems in Chinese culture. Concurrently, this study also focuses on exploring trans-diagonostic risk and proctective factors underline HiTOP dimensions. the main questions it aims to answer are: 1. Explore HiTOP model cultural differences between western culture and eastern culture. 2. Understand the impact of different dimension of adverse childhood experience on HiTOP structure. 3. Investigate the relationship between individual unique psychological variables and psychopathological dimensions. Participants will receive a detailed survey trying to measure their psychopathology symptoms, adverse childhood experience and psychological variables. This study expects to fallow up participants for 4 years to monitor the symptom changes.

Eligibility Criteria

Inclusion Criteria: 1. Chinese citizens 2. Years of education \> =9 years. 3. age \>= 18 years old. Exclusion Criteria: (1)Subjects who have insufficient self-awareness, and are unable to obtain complete informed consent, such as: schizophrenia, manic episode of bipolar disorder, severe depression.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology